13 terminated. 13 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Terminated 13 |
| Phase 3 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Mitomycin: new trials by email Literature Review of Mitomycin trials Research Report on Mitomycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma gemcitabine, Cisplatin, Conventional TACE (transarterial chemoembolization) with Doxorubicin/Mitomycin-C - Unresectable Intrahepatic Cholangiocarcinoma | Phase 2 | Terminated | Yale University | 1 | 2017-06-21 | 2019-12-30 |
| Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma 5-FU, Mitomycin, sorafenib - Carcinoma, Hepatocellular | Phase 2 | Terminated | Seoul National University Hospital | 5 | 2015-11-01 | 2017-04-26 |
| Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer CG0070 Adenovirus Vector, Control Arm: Quadruple Choice - Transitional Cell Carcinoma, Bladder Cancer | Phase 2 / Phase 3 | Terminated | CG Oncology, Inc. | 22 | 2014-03-01 | 2021-04-14 |
| A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer Treatment, 5FU, Mitomycin - Anal Cancer | Phase 1 / Phase 2 | Terminated | Brown University | 11 | 2013-02-01 | 2020-02-17 |
| Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal RADIOTHERAPY, PANITUMUMAB, MITOMYCIN - Carcinoma of Anal Canal | Phase 2 | Terminated | Centre Hospitalier Universitaire Vaudois | 8 | 2012-12-01 | 2016-05-19 |
| Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer ifosfamide, mitomycin C - Pancreatic Cancer | Phase 2 | Terminated | IRCCS San Raffaele | 21 | 2006-03-01 | 2012-02-01 |
| A Study of Mitomycin C, Irinotecan, and Cetuximab Mitomycin C, Cetuximab, Irinotecan. - Colorectal Cancer | Phase 2 | Terminated | University of Michigan Rogel Cancer Center | 13 | 2005-12-01 | 2015-12-03 |
| Individualized Drug Treatment for Treating Patients With Pancreatic Cancer cetuximab, capecitabine, docetaxel - Pancreatic Cancer | Phase 2 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 249 | 2005-10-01 | 2018-10-24 |
| Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites mitomycin C - Metastatic Cancer | Phase 2 | Terminated | Masonic Cancer Center, University of Minnesota | 1 | 2004-08-01 | 2017-11-29 |
| Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer cisplatin, fluorouracil, mitomycin C - Anal Cancer | Phase 2 / Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 88 | 2003-07-01 | 2012-09-24 |
| Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus sargramostim, cisplatin, dacarbazine - Sarcoma | Phase 2 | Terminated | Gynecologic Oncology Group | 2002-03-01 | 2013-04-11 | |
| Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer chemotherapy, fluorouracil, leucovorin calcium - Colorectal Cancer, Metastatic Cancer | Phase 2 | Terminated | UNICANCER | 1999-07-01 | 2021-02-17 | |
| Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus cisplatin, doxorubicin hydrochloride, mitomycin C - Sarcoma | Phase 2 | Terminated | Gynecologic Oncology Group | 30 | 1997-08-01 | 2013-07-09 |
Anus Neoplasms (2) · Colorectal Neoplasms (2) · Neoplasm Metastasis (2) · Pancreatic Neoplasms (2) · Sarcoma (2) · Adenoviridae Infections (1) · Anal Canal Carcinoma (1) · Carcinoma in Situ (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Transitional Cell (1) · Colonic Neoplasms (1) · Neoplasms (1) · Rectal Neoplasms (1) · Urinary Bladder Neoplasms (1) · Virus Diseases (1)
Gynecologic Oncology Group (2) · Brown University (1) · CG Oncology, Inc. (1) · Centre Hospitalier Universitaire Vaudois (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · IRCCS San Raffaele (1) · Masonic Cancer Center, University of Minnesota (1) · Seoul National University Hospital (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · UNICANCER (1) · University of Michigan Rogel Cancer Center (1) · Yale University (1)
United States (8) · Belgium (2) · France (2) · Italy (2) · Egypt (1) · Germany (1) · Netherlands (1) · Norway (1) · Serbia (1) · South Korea (1) · Switzerland (1)
Alex W Yeung, MBBS (1) · Daniel A. Laheru, MD (1) · Dominique Elias, MD (1) · Harry J. Long, MD (1) · Howard Safran, MD (1) · Jean-Francois Bosset, MD (1) · John H. Edmonson, MD (1) · Jung-Hwan Yoon, M.D., Ph.D. (1) · Mark Zalupski, M.D. (1) · Michele Reni, MD (1) · Oscar Matzinger, MD (1) · Todd M. Tuttle, MD (1) · Todd Schlachter (1)
PMID 12051882, PMID 16051328, PMID 19643599, PMID 21135251
P30CA006973 (1)